Wouldn't say 'thumbed their nose' per se, but in the most recent...

Wouldn't say 'thumbed their nose' per se, but in the most recent capital raise, 46m shares went to institutions and 6.5m went to the SPP - oversubscribed and scaled back.

The same happened with the 2014 CR - much to the chagrin of many on this forum.

Over the years when no insto would come within cooee, the retail investors have coughed up time and time again.

As one poster put it:
Resolution 8 is basically a blank check to raise 15% equity above and beyond the normal 10%. So if we think about it the company has ~40m in cash and they have the ability to raise another 30m in any given year with the market cap at ~300m under standard rules. They are asking us for blind permission to raise another theoretical 45M on top of the 30M or get to a total of ~115M in cash.

I only suggest it is a resolution worth considering deeply in light of current cash reserves, clinical progress & SP.